Lysine demethylase 5C(KDM5C) is a member of the evolutionarily conserved KDM5 family and act as a histone demethylase to regulate H3K4me2/me3 levels on chromosomes. Recent researches have shown that KDM5C is misregulated in colorectal cancer, liver cancer, gastric cancer, breast cancer, renal cell cancer, prostate cancer and others. KDM5C is involved in the regulation of the expression of tumor-related genes, related to the proliferation, migration, invasion and prognosis of tumor cells. A better understanding of the pathogenetic mechanisms and biologic functions of KDM5C in tumor is expected to provide novel opportunities for the diagnosis and treatment of tumors. This paper reviews the research progress of KDM5C in various tumors.
| Published in | Asia-Pacific Journal of Medicine (Volume 2, Issue 3) |
| Page(s) | 21-27 |
| Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
| Copyright |
Copyright © The Author(s), 2024. Published by Science Publishing Group |
KDM5C, Lysine Demethylase 5C, Tumor
| [1] | Wu J, Salido EC, Yen PH, Mohandas TK, Heng HH, Tsui LC, Park J, Chapman VM, Shapiro LJ. The murine Xe169 gene escapes X-inactivation like its human homologue. NAT GENET 1994; 7(4): 491-496 [PMID: 7951318 DOI: 10.1038/ng0894-491]. |
| [2] | Wu J, Ellison J, Salido E, Yen P, Mohandas T, Shapiro LJ. Isolation and characterization of XE169, a novel human gene that escapes X-inactivation. HUM MOL GENET 1994; 3(1): 153-160 [PMID: 8162017 DOI: 10.1093/hmg/3.1.153]. |
| [3] | Jensen LR, Amende M, Gurok U, Moser B, Gimmel V, Tzschach A, Janecke AR, Tariverdian G, Chelly J, Fryns JP, Van Esch H, Kleefstra T, Hamel B, Moraine C, Gecz J, Turner G, Reinhardt R, Kalscheuer VM, Ropers HH, Lenzner S. Mutations in the JARID1C gene, which is involved in transcriptional regulation and chromatin remodeling, cause X-linked mental retardation. AM J HUM GENET 2005; 76(2): 227-236 [PMID: 15586325 DOI:10.1086/427563] |
| [4] | Iwase S, Lan F, Bayliss P, de la Torre-Ubieta L, Huarte M, Qi HH, Whetstine JR, Bonni A, Roberts TM, Shi Y. The X-linked mental retardation gene SMCX/JARID1C defines a family of histone H3 lysine 4 demethylases. CELL 2007; 128(6): 1077-1088 [PMID: 17320160 DOI:10.1016/j.cell.2007.02.017]. |
| [5] | Klose RJ, Yamane K, Bae Y, Zhang D, Erdjument-Bromage H, Tempst P, Wong J, Zhang Y. The transcriptional repressor JHDM3A demethylates trimethyl histone H3 lysine 9 and lysine 36. NATURE 2006; 442(7100): 312-316 [PMID: 16732292 DOI:10.1038/nature04853]. |
| [6] | Christensen J, Agger K, Cloos PA, Pasini D, Rose S, Sennels L, Rappsilber J, Hansen KH, Salcini AE, Helin K. RBP2 belongs to a family of demethylases, specific for tri-and dimethylated lysine 4 on histone 3. CELL 2007; 128(6): 1063-1076 [PMID: 17320161 DOI:10.1016/j.cell.2007.02.003]. |
| [7] | Huang F, Chandrasekharan MB, Chen YC, Bhaskara S, Hiebert SW, Sun ZW. The JmjN domain of Jhd2 is important for its protein stability, and the plant homeodomain (PHD) finger mediates its chromatin association independent of H3K4 methylation. J BIOL CHEM 2010; 285(32): 24548-24561 [PMID: 20538609 DOI:10.1074/jbc.M110.117333] |
| [8] | Seward DJ, Cubberley G, Kim S, Schonewald M, Zhang L, Tripet B, Bentley DL. Demethylation of trimethylated histone H3 Lys4 in vivo by JARID1 JmjC proteins. Nat Struct Mol Biol 2007; 14(3):240-242 [PMID: 17310255 DOI: 10.1038/nsmb1200]. |
| [9] | Wilsker D, Probst L, Wain HM, Maltais L, Tucker PW, Moran E. Nomenclature of the ARID family of DNA-binding proteins. Genomics 2005; 86(2):242-51.[PMID: 15922553 DOI: 10.1016/j.ygeno.2005.03.013]. |
| [10] | Patsialou A, Wilsker D, Moran E. DNA-binding properties of ARID family proteins. Nucleic Acids Res 2005;33(1):66-80[PMID: 15640446 DOI: 10.1093/nar/gki145]. |
| [11] | Lee MG, Norman J, Shilatifard A, Shiekhattar R. Physical and functional association of a trimethyl H3K4 demethylase and Ring6a/MBLR, a polycomb-like protein. Cell 2007;128(5):877-87 [PMID: 17320162 DOI: 10.1016/j.cell.2007.02.004]. |
| [12] | Jensen LR, Bartenschlager H, Rujirabanjerd S, Tzschach A, Numann A, Janecke AR, Sporle R, Stricker S, Raynaud M, Nelson J, Hackett A, Fryns JP, Chelly J, de Brouwer AP, Hamel B, Gecz J, Ropers HH, Kuss AW. A distinctive gene expression fingerprint in mentally retarded male patients reflects disease-causing defects in the histone demethylase KDM5C. Pathogenetics 2010; 3(1): 2 [PMID: 20181063 DOI: 10.1186/1755-8417-3-2]. |
| [13] | Shi Y, Whetstine JR. Dynamic regulation of histone lysine methylation by demethylases. MOL CELL 2007; 25(1): 1-14 [PMID: 17218267 DOI: 10.1016/j.molcel.2006.12.010]. |
| [14] | Fodor BD, Kubicek S, Yonezawa M, O'Sullivan RJ, Sengupta R, Perez-Burgos L, Opravil S, Mechtler K, Schotta G, Jenuwein T. Jmjd2b antagonizes H3K9 trimethylation at pericentric heterochromatin in mammalian cells. Genes Dev 2006; 20(12): 1557-1562 [PMID: 16738407 DOI: 10.1101/gad.388206]. |
| [15] | Kawazu M, Saso K, Tong KI, McQuire T, Goto K, Son DO, Wakeham A, Miyagishi M, Mak TW, Okada H. Histone demethylase JMJD2B functions as a co-factor of estrogen receptor in breast cancer proliferation and mammary gland development. PLOS ONE 2011; 6(3): e17830 [PMID: 21445275 DOI: 10.1371/journal.pone.0017830] |
| [16] | Cox BJ, Vollmer M, Tamplin O, Lu M, Biechele S, Gertsenstein M, van Campenhout C, Floss T, Kuhn R, Wurst W, Lickert H, Rossant J. Phenotypic annotation of the mouse X chromosome. GENOME RES 2010; 20(8): 1154-1164 [PMID: 20548051 DOI: 10.1101/gr.105106.110]. |
| [17] | Catchpole S, Spencer-Dene B, Hall D, Santangelo S, Rosewell I, Guenatri M, Beatson R, Scibetta AG, Burchell JM, Taylor-Papadimitriou J. PLU-1/JARID1B/KDM5B is required for embryonic survival and contributes to cell proliferation in the mammary gland and in ER+ breast cancer cells. INT J ONCOL 2011; 38(5): 1267-1277 [PMID: 21369698 DOI: 10.3892/ijo.2011.956]. |
| [18] | Tahiliani M, Mei P, Fang R, Leonor T, Rutenberg M, Shimizu F, Li J, Rao A, Shi Y. The histone H3K4 demethylase SMCX links REST target genes to X-linked mental retardation. NATURE 2007; 447(7144): 601-605 [PMID: 17468742 DOI:10.1038/nature05823]. |
| [19] | Tsukada Y, Fang J, Erdjument-Bromage H, Warren ME, Borchers CH, Tempst P, Zhang Y. Histone demethylation by a family of JmjC domain-containing proteins. NATURE 2006; 439(7078): 811-816 [PMID: 16362057 DOI: 10.1038/nature04433]. |
| [20] | Outchkourov NS, Muino JM, Kaufmann K, van Ijcken WF, Groot KM, van Leenen D, de Graaf P, Holstege FC, Grosveld FG, Timmers HT. Balancing of histone H3K4 methylation states by the Kdm5c/SMCX histone demethylase modulates promoter and enhancer function. CELL REP 2013; 3(4): 1071-1079 [PMID: 23545502 DOI:10.1016/j.celrep.2013.02.030]. |
| [21] | Shen H, Xu W, Guo R, Rong B, Gu L, Wang Z, He C, Zheng L, Hu X, Hu Z, Shao ZM, Yang P, Wu F, Shi YG, Shi Y, Lan F. Suppression of Enhancer Overactivation by a RACK7-Histone Demethylase Complex. CELL 2016; 165(2): 331-342 [PMID: 27058665 DOI:10.1016/j.cell.2016.02.064]. |
| [22] | Wesche J, Kuhn S, Kessler BM, Salton M, Wolf A. Protein arginine methylation: a prominent modification and its demethylation. CELL MOL LIFE SCI 2017; 74(18): 3305-3315 [PMID: 28364192 DOI: 10.1007/s00018-017-2515-z] |
| [23] | Puccini A, Lenz HJ, Marshall JL, Arguello D, Raghavan D, Korn WM, Weinberg BA, Poorman K, Heeke AL, Philip PA, Shields AF, Goldberg RM, Salem ME. Impact of Patient Age on Molecular Alterations of Left-Sided Colorectal Tumors. ONCOLOGIST 2018 [PMID: 30018131 DOI: 10.1634/theoncologist.2018-0117]. |
| [24] | Lin H, Yang G, Yu J, Wang J, Li Q, Guo S, Cao B. KDM5c inhibits multidrug resistance of colon cancer cell line by down-regulating ABCC1. BIOMED PHARMACOTHER 2018; 107: 1205-1209 [PMID: 30257334 DOI: 10.1016/j.biopha.2018.08.041]. |
| [25] | Ji X, Jin S, Qu X, Li K, Wang H, He H, Guo F, Dong L. Lysine-specific demethylase 5C promotes hepatocellular carcinoma cell invasion through inhibition BMP7 expression. BMC CANCER 2015; 15: 801 [PMID: 26503415 DOI: 10.1186/s12885-015-1798-4]. |
| [26] | 胡敏敏，詹浩炼，刘丽璇，项梦琦，蒲泽锦，李国平，吴灵飞. KDM5C基因shRNA重组慢病毒载体的构建及其对肝癌HepG2细胞的增殖和迁移的影响[J].世界华人消化杂志，2017(8):691-701. |
| [27] | Xu L, Wu W, Cheng G, Qian M, Hu K, Yin G, Wang S. Enhancement of Proliferation and Invasion of Gastric Cancer Cell by KDM5C Via Decrease in p53 Expression. Technol Cancer Res Treat 2017; 16(2): 141-149 [PMID: 26858085 DOI: 10.1177/1533034616629261]. |
| [28] | Yang P, Du CW, Kwan M, Liang SX, Zhang GJ. The impact of p53 in predicting clinical outcome of breast cancer patients with visceral metastasis. Sci Rep 2013; 3: 2246 [PMID: 23873310 DOI: 10.1038/srep02246]. |
| [29] | Geng SQ, Alexandrou AT, Li JJ. Breast cancer stem cells: Multiple capacities in tumor metastasis. CANCER LETT 2014; 349(1): 1-7 [PMID: 24727284 DOI: 10.1016/j.canlet.2014.03.036]. |
| [30] | Patani N, Jiang WG, Newbold RF, Mokbel K. Histone-modifier gene expression profiles are associated with pathological and clinical outcomes in human breast cancer. ANTICANCER RES 2011; 31(12): 4115-4125 [PMID: 22199269]. |
| [31] | Wang Q, Wei J, Su P, Gao P. Histone demethylase JARID1C promotes breast cancer metastasis cells via down regulating BRMS1 expression. Biochem Biophys Res Commun 2015; 464(2): 659-666 [PMID: 26182878 DOI: 10.1016/j.bbrc.2015.07.049]. |
| [32] | Liu Y, Mayo MW, Xiao A, Hall EH, Amin EB, Kadota K, Adusumilli PS, Jones DR. Loss of BRMS1 promotes a mesenchymal phenotype through NF-kappaB-dependent regulation of Twist1. MOL CELL BIOL 2015; 35(1): 303-317 [PMID: 25368381 DOI: 10.1128/MCB.00869-14]. |
| [33] | Smith J, Naseem R, Webb M. Purification and characterisation of the breast cancer metastasis suppressor, BRMS1. Protein Expr Purif 2009; 67(2): 70-75 [PMID: 19401233 DOI: 10.1016/j.pep.2009.04.010] |
| [34] | Denis H, Van Grembergen O, Delatte B, Dedeurwaerder S, Putmans P, Calonne E, Rothe F, Sotiriou C, Fuks F, Deplus R. MicroRNAs regulate KDM5 histone demethylases in breast cancer cells. MOL BIOSYST 2016; 12(2): 404-413 [PMID: 26621457 DOI: 10.1039/c5mb00513b]. |
| [35] | Baldewijns MM, van Vlodrop IJ, Vermeulen PB, Soetekouw PM, van Engeland M, de Bruine AP. VHL and HIF signalling in renal cell carcinogenesis. J PATHOL 2010; 221(2): 125-138 [PMID: 20225241 DOI: 10.1002/path.2689] |
| [36] | Niu X, Zhang T, Liao L, Zhou L, Lindner DJ, Zhou M, Rini B, Yan Q, Yang H. The von Hippel-Lindau tumor suppressor protein regulates gene expression and tumor growth through histone demethylase JARID1C. ONCOGENE 2012; 31(6): 776-786 [PMID: 21725364 DOI: 10.1038/onc.2011.266]. |
| [37] | Dalgliesh GL, Furge K, Greenman C, Chen L, Bignell G, Butler A, Davies H, Edkins S, Hardy C, Latimer C, Teague J, Andrews J, Barthorpe S, Beare D, Buck G, Campbell PJ, Forbes S, Jia M, Jones D, Knott H, Kok CY, Lau KW, Leroy C, Lin ML, McBride DJ, Maddison M, Maguire S, McLay K, Menzies A, Mironenko T, Mulderrig L, Mudie L, O'Meara S, Pleasance E, Rajasingham A, Shepherd R, Smith R, Stebbings L, Stephens P, Tang G, Tarpey PS, Turrell K, Dykema KJ, Khoo SK, Petillo D, Wondergem B, Anema J, Kahnoski RJ, Teh BT, Stratton MR, Futreal PA. Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes. NATURE 2010; 463(7279): 360-363 [PMID: 20054297 DOI: 10.1038/nature08672]. |
| [38] | Gossage L, Murtaza M, Slatter AF, Lichtenstein CP, Warren A, Haynes B, Marass F, Roberts I, Shanahan SJ, Claas A, Dunham A, May AP, Rosenfeld N, Forshew T, Eisen T. Clinical and pathological impact of VHL, PBRM1, BAP1, SETD2, KDM6A, and JARID1c in clear cell renal cell carcinoma. Genes Chromosomes Cancer 2014; 53(1): 38-51 [PMID: 24166983 DOI: 10.1002/gcc.22116]. |
| [39] | Varela I, Tarpey P, Raine K, Huang D, Ong CK, Stephens P, Davies H, Jones D, Lin ML, Teague J, Bignell G, Butler A, Cho J, Dalgliesh GL, Galappaththige D, Greenman C, Hardy C, Jia M, Latimer C, Lau KW, Marshall J, McLaren S, Menzies A, Mudie L, Stebbings L, Largaespada DA, Wessels LF, Richard S, Kahnoski RJ, Anema J, Tuveson DA, Perez-Mancera PA, Mustonen V, Fischer A, Adams DJ, Rust A, Chan-on W, Subimerb C, Dykema K, Furge K, Campbell PJ, Teh BT, Stratton MR, Futreal PA. Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma. NATURE 2011; 469(7331): 539-542 [PMID: 21248752 DOI: 10.1038/nature09639]. |
| [40] | Comprehensive molecular characterization of clear cell renal cell carcinoma. NATURE 2013; 499(7456): 43-49 [PMID: 23792563 DOI: 10.1038/nature12222]. |
| [41] | Rondinelli B, Rosano D, Antonini E, Frenquelli M, Montanini L, Huang D, Segalla S, Yoshihara K, Amin SB, Lazarevic D, The BT, Verhaak RG, Futreal PA, Di Croce L, Chin L, Cittaro D, Tonon G. Histone demethylase JARID1C inactivation triggers genomic instability in sporadic renal cancer. J CLIN INVEST 2015; 125(12): 4625-4637 [PMID: 26551685 DOI:10.1172/JCI81040]. |
| [42] | Stein J, Majores M, Rohde M, Lim S, Schneider S, Krappe E, Ellinger J, Dietel M, Stephan C, Jung K, Perner S, Kristiansen G, Kirfel J. KDM5C is overexpressed in prostate cancer and is a prognostic marker for prostate-specific antigen-relapse following radical prostatectomy. AM J PATHOL 2014; 184(9): 2430-2437 [PMID: 25016185 DOI: 10.1016/j.ajpath.2014.05.022]. |
| [43] | Hong Z, Wu G, Xiang ZD, Xu CD, Huang SS, Li C, Shi L, Wu DL. KDM5C is transcriptionally regulated by BRD4 and promotes castration-resistance prostate cancer cell proliferation by repressing PTEN. BIOMED PHARMACOTHER 2019; 114: 108793 [PMID: 30921702 DOI: 10.1016/j.biopha.2019.108793]. |
| [44] | Smith JA, White EA, Sowa ME, Powell ML, Ottinger M, Harper JW, Howley PM. Genome-wide siRNA screen identifies SMCX, EP400, and Brd4 as E2-dependent regulators of human papillomavirus oncogene expression. Proc Natl Acad Sci USA 2010;107(8):3752-7.[PMID: 20133580 DOI: 10.1073/pnas.0914818107]. |
| [45] | Chen X, Loo JX, Shi X, Xiong W, Guo Y, Ke H, Yang M, Jiang Y, Xia S, Zhao M, Zhong S, He C, Fu L, Li F. E6 Protein Expressed by High-Risk HPV Activates Super-Enhancers of the EGFR and c-MET Oncogenes by Destabilizing the Histone Demethylase KDM5C. CANCER RES 2018; 78(6): 1418-1430 [PMID: 29339538 DOI: 10.1158/0008-5472.CAN-17-2118]. |
| [46] | Ricketts CJ, Linehan WM. Gender Specific Mutation Incidence and Survival Associations in Clear Cell Renal Cell Carcinoma (CCRCC). PLOS ONE 2015; 10(10): e140257 [PMID: 26484545 DOI: 10.1371/journal.pone.0140257]. |
| [47] | Dunford A, Weinstock DM, Savova V, Schumacher SE, Cleary JP, Yoda A, Sullivan TJ, Hess JM, Gimelbrant AA, Beroukhim R, Lawrence MS, Getz G, Lane AA. Tumor-suppressor genes that escape from X-inactivation contribute to cancer sex bias. NAT GENET 2017; 49(1): 10-16 [PMID: 27869828 DOI: 10.1038/ng.3726]. |
| [48] | Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. NUCLEIC ACIDS RES 2017; 45(W1): W98-W102 [PMID: 28407145 DOI: 10.1093/nar/gkx247]. |
APA Style
Zhe Liu, Lingfei Wu. (2019). Progress in Research of KDM5C in Human Tumors. Asia-Pacific Journal of Medicine, 2(3), 21-27.
ACS Style
Zhe Liu; Lingfei Wu. Progress in Research of KDM5C in Human Tumors. Asia-Pac. J. Med. 2019, 2(3), 21-27.
Share This Article
Twitter
Linked In
Facebook
Copy
Download@article{10043442,
author = {Zhe Liu and Lingfei Wu},
title = {Progress in Research of KDM5C in Human Tumors},
journal = {Asia-Pacific Journal of Medicine},
volume = {2},
number = {3},
pages = {21-27},
url = {https://www.sciencepublishinggroup.com/article/10043442},
abstract = {Lysine demethylase 5C(KDM5C) is a member of the evolutionarily conserved KDM5 family and act as a histone demethylase to regulate H3K4me2/me3 levels on chromosomes. Recent researches have shown that KDM5C is misregulated in colorectal cancer, liver cancer, gastric cancer, breast cancer, renal cell cancer, prostate cancer and others. KDM5C is involved in the regulation of the expression of tumor-related genes, related to the proliferation, migration, invasion and prognosis of tumor cells. A better understanding of the pathogenetic mechanisms and biologic functions of KDM5C in tumor is expected to provide novel opportunities for the diagnosis and treatment of tumors. This paper reviews the research progress of KDM5C in various tumors.},
year = {2019}
}
TY - JOUR T1 - Progress in Research of KDM5C in Human Tumors AU - Zhe Liu AU - Lingfei Wu Y1 - 2019/11/18 PY - 2019 T2 - Asia-Pacific Journal of Medicine JF - Asia-Pacific Journal of Medicine JO - Asia-Pacific Journal of Medicine SP - 21 EP - 27 PB - Science Publishing Group UR - http://www.sciencepg.com/article/10043442 AB - Lysine demethylase 5C(KDM5C) is a member of the evolutionarily conserved KDM5 family and act as a histone demethylase to regulate H3K4me2/me3 levels on chromosomes. Recent researches have shown that KDM5C is misregulated in colorectal cancer, liver cancer, gastric cancer, breast cancer, renal cell cancer, prostate cancer and others. KDM5C is involved in the regulation of the expression of tumor-related genes, related to the proliferation, migration, invasion and prognosis of tumor cells. A better understanding of the pathogenetic mechanisms and biologic functions of KDM5C in tumor is expected to provide novel opportunities for the diagnosis and treatment of tumors. This paper reviews the research progress of KDM5C in various tumors. VL - 2 IS - 3 ER -
Information
Email: